HIV/AIDS

HIV/AIDS 2017-07-09T16:10:10+00:00

What is HIV?

Human Immunodeficiency Virus (HIV) attacks the body’s immune system by destroying the system’s white blood cells, known as T cells. HIV is spread by contact with infected bodily fluids such as blood, semen, vaginal fluids, and breast milk. If an individual is already infected, taking a regular dosage of antiretroviral therapy (ART) can reduce the amount of HIV virus in the blood and can reduce the risk of transmission to others. Currently, there is no safe and effective cure, but scientists are working hard to discover and develop one.

What is AIDS?

Acquired Immunodeficiency Syndrome (AIDS) is the final stage of HIV infection, determined when an individual’s T cell count is below 200. Individuals with AIDS are more likely to develop Opportunistic Infections that often lead to death.

Resources

In the News

  • Global Health Week events planned February 21, 2018
    It features filmmaker Carl Gierstorfer and Science magazine writer Jon Cohen's reporting on Ebola and HIV/AIDS. The events are free and open to the public; visit the Global Health Week website to learn more and register. Global Health Week is sponsored by the McDonnell International Scholars ...
  • New PrEP PSA Unveiled at National Black HIV/AIDS Awareness Day Conference February 21, 2018
    The National Black Leadership Coalition on AIDS – Detroit Chapter hosted a National Black HIV/AIDS Awareness Day conference on Friday at Michigan State University – Detroit Center. The conference, which attracted around 25 people, marked the premiere of UNIFIED – HIV Health & Beyond's new ...
  • FDA Tentatively Approves Once-Daily, Fixed Dose Combination HIV Treatment February 21, 2018
    “In the past decade, Mylan has committed itself again and again to bringing new therapeutic options to people living with HIV as quickly as possible and to as many people as possible,” said Rajiv Malik, president, Mylan. “We are proud that nearly half of the FDA's tentative approvals under PEPFAR are ...
  • Bias by Insurers Over a Drug to Prevent HIV February 21, 2018
    Discrimination by insurance companies against people taking the drug Truvada as an effective H.I.V. prevention method shows us that we still have a long way to go to educate insurers and other health officials about the realities of H.I.V.-AIDS. This kind of “other” treatment also harkens to the darkest ...
  • Depression May Impede HIV Care (JAMA Psychiatry February 21, 2018
    People with depression may have a harder time sticking to their HIV treatment plans, a new study in JAMA Psychiatry suggested. Depression was associated with greater rates of missing scheduled healthcare visits and higher rates of detectable viral loads, as well as with poorer survival.